Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abaxis Inc (ABAX)

Abaxis Inc (ABAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abaxis Inc 3240 WHIPPLE ROAD UNION CITY CA 94587 USA

www.abaxis.com P: 510-675-6500

Description:

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Their mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. The Company provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices.

Key Statistics

Overview:

Market Capitalization, $K 1,898,210
Shares Outstanding, K 22,870
Annual Sales, $ 244,700 K
Annual Net Income, $ 27,180 K
Last Quarter Sales, $ 67,920 K
Last Quarter Net Income, $ 10,020 K
60-Month Beta 1.30
% of Insider Shareholders 4.30%
% of Institutional Shareholders 90.23%

Growth:

1-Year Return 74.30%
3-Year Return 70.54%
5-Year Return 107.34%
5-Year Revenue Growth 31.54%
5-Year Earnings Growth 4.88%
5-Year Dividend Growth -40.00%

Per-Share Information:

Most Recent Earnings 0.42 on 04/26/18
Next Earnings Date 08/02/18
Earnings Per Share ttm 1.30
EPS Growth vs. Prev Qtr 35.48%
EPS Growth vs. Prev Year 27.27%
Annual Dividend Rate, $ 0.72
Annual Dividend Yield 0.87%
Most Recent Dividend 0.180 on 05/31/18
Next Ex-Dividends Date 05/31/18
Dividend Payable Date 06/15/18
Dividend Payout Ratio -45.63%

ABAX Ratios

Ratio
Price/Earnings ttm 63.92
Price/Earnings forward 56.39
Price/Earnings to Growth 5.51
Return-on-Equity % 10.65%
Return-on-Assets % 9.12%
Profit Margin % 11.11%
Debt/Equity 0.00
Price/Sales 7.77
Price/Cash Flow 48.41
Price/Book 6.48
Book Value/Share 12.81
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar